At this time, posts about Myeongmun Pharmaceutical are rapidly increasing on portals and securities communities, while foreign investors are tentatively estimated to have net sold 59,000 shares today. Myeongmun Pharmaceutical is known as a comprehensive pharmaceutical company focusing on prescription drugs.


As of 11:30 AM on the 5th, Myeongmun Pharmaceutical's stock price is 7,540 KRW, up 8.02% from the previous day, with a trading volume of 38,015,128 shares, which is 308.12% of the average trading volume on the 5th. On September 29, Myeongmun Pharmaceutical became an issue in the market with the headline 'Iyeon Pharmaceutical surged sharply on the afternoon of the 29th... the background.'


In addition to Myeongmun Pharmaceutical, posts by investors are also rapidly increasing for Naivec (138610), Hanseong Enterprise (003680), and Andyforce (238090).



※Source: AI Investment Assistant AI Lassi


※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing